Management of the post chemotherapy subcentimeter residual mass: the case for observation

被引:6
作者
Beck, Stephen D. W. [1 ]
Foster, Richard S. [1 ]
机构
[1] Indiana Univ, Dept Urol, Indianapolis, IN 46202 USA
关键词
GERM-CELL TUMORS; LYMPH-NODE DISSECTION; CLINICAL STAGE-I; POSTCHEMOTHERAPY RETROPERITONEAL SURGERY; NONSEMINOMATOUS TESTICULAR CANCER; LATE RELAPSE; ADJUVANT CHEMOTHERAPY; MULTIVARIATE-ANALYSIS; LATE RECURRENCE; TESTIS CANCER;
D O I
10.1007/s00345-009-0452-7
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:485 / 488
页数:4
相关论文
共 27 条
[1]   Randomized phase III trial comparing retroperitoneal lymph node dissection with one course of bleomycin and etoposide plus cisplatin chemotherapy in the adjuvant treatment of clinical stage I nonseminomatous testicular germ cell tumors: AUO trial AH 01/94 by the German testicular cancer study group [J].
Albers, Peter ;
Siener, Roswitha ;
Krege, Susanne ;
Schmelz, Hans-Uwe ;
Dieckmann, Klaus-Peter ;
Heidenreich, Axel ;
Kwasny, Peter ;
Pechoel, Maik ;
Lehmann, Jan ;
Kliesch, Sabine ;
Koehrmann, Kai-Uwe ;
Fimmers, Rolf ;
Weissbach, Lothar ;
Loy, Volker ;
Wittekind, Christian ;
Hartmann, Michael .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (18) :2966-2972
[2]   LATE RELAPSE OF TESTICULAR CANCER [J].
BANIEL, J ;
FOSTER, RS ;
GONIN, R ;
MESSEMER, JE ;
DONOHUE, JP ;
EINHORN, LH .
JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (05) :1170-1176
[3]   LATE RECURRENCE OF TESTICULAR CANCER [J].
BORGE, N ;
FOSSA, SD ;
OUS, S ;
STENWIG, AE ;
LIEN, HH .
JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (08) :1248-1253
[4]   Refining the optimal chemotherapy regimen for good-risk metastatic nonseminomatous germ-cell tumors:: a randomized trial of the Genito-Urinary Group of the French Federation of Cancer Centers (GETUG T9313P) [J].
Culine, S. ;
Kerbrat, P. ;
Kramar, A. ;
Theodore, C. ;
ChevreauU, C. ;
Geoffrois, L. ;
Bui, N. B. ;
Peny, J. ;
Caty, A. ;
Delva, R. ;
Biron, P. ;
Fizazi, K. ;
Bouzy, J. ;
Droz, J. P. .
ANNALS OF ONCOLOGY, 2007, 18 (05) :917-924
[5]   Short-course adjuvant chemotherapy in high-risk stage I nonseminomatous germ cell tumors of the testis: A medical research council report [J].
Cullen, MH ;
Stenning, SP ;
Parkinson, MC ;
Fossa, SD ;
Kaye, SB ;
Horwich, AH ;
Harland, SJ ;
Williams, MV ;
Jakes, R .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (04) :1106-1113
[6]   The indication for postchemotherapy lymph node dissection in clinical stage IS nonseminomatous germ cell tumor [J].
Dash, Atreya ;
Carver, Breff S. ;
Stasi, Jason ;
Bajorin, Dean F. ;
Motzer, Robert J. ;
Bosl, George J. ;
Sheinfeld, Joel .
CANCER, 2008, 112 (04) :800-805
[7]   Decision analysis for avoiding postchemotherapy surgery in patients with disseminated nonseminomatous germ cell tumors [J].
Debono, DJ ;
Heilman, DK ;
Einhorn, LH ;
Donohue, JP .
JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (04) :1455-1464
[8]   Late relapse of testicular germ cell neoplasms:: A descriptive analysis of 122 cases [J].
Dieckmann, KP ;
Albers, P ;
Classen, J ;
De Wit, M ;
Pichlmeier, U ;
Rick, O ;
Müllerleile, U ;
Kuczyk, M .
JOURNAL OF UROLOGY, 2005, 173 (03) :824-829
[9]   CORRELATION OF COMPUTERIZED TOMOGRAPHIC CHANGES AND HISTOLOGICAL-FINDINGS IN 80 PATIENTS HAVING RADICAL RETROPERITONEAL LYMPH-NODE DISSECTION AFTER CHEMOTHERAPY FOR TESTIS CANCER [J].
DONOHUE, JP ;
ROWLAND, RG ;
KOPECKY, K ;
STEIDLE, CP ;
GEIER, G ;
NEY, KG ;
EINHORN, L ;
WILLIAMS, S ;
LOEHRER, P .
JOURNAL OF UROLOGY, 1987, 137 (06) :1176-1179
[10]   EVALUATION OF OPTIMAL DURATION OF CHEMOTHERAPY IN FAVORABLE-PROGNOSIS DISSEMINATED GERM-CELL TUMORS - A SOUTHEASTERN-CANCER-STUDY-GROUP PROTOCOL [J].
EINHORN, LH ;
WILLIAMS, SD ;
LOEHRER, PJ ;
BIRCH, R ;
DRASGA, R ;
OMURA, G ;
GRECO, FA .
JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (03) :387-391